Trump pharma tariff seen as needle prick for China, disruptive for U.S.

Trump pharma tariff seen as needle prick for China, disruptive for U.S.

U.S. President Donald Trump’s latest threat to impose steep blanket tariffs on a range of imports that includes drugs underscores another key friction point in the economic rivalry between Washington and Beijing: America’s reliance on Chinese medical supplies.

Trump last week said he was considering new duties of around 25% on pharmaceutical products, along with automobiles and semiconductors, as early as April. The tariff rates will “go very substantially higher over a course of a year,” he said, but companies that set up domestic facilities would be exempted.